NASDAQ$SDGR
Schrodinger Inc/United States · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Schrödinger reported strong fourth quarter and full-year 2024 financial results, with total revenue increasing by 19.1% and software revenue growing by 16.0% compared to the previous year.
Schrödinger delivered a strong performance in Q4 2024, with total revenue reaching $88.3 million, a 19.1% increase year-over-year, driven by robust software revenue growth of 16.0% to $79.7 million and a significant 58% increase in drug discovery revenue to $8.7 million. Despite the revenue growth, the company reported a net loss of $40.2 million for the quarter.
- Total revenue for Q4 2024 increased 19.1% to $88.3 million, compared to $74.1 million in Q4 2023.
- Software revenue for Q4 2024 increased 16.0% to $79.7 million, primarily due to increased hosted revenue from large customers and new multi-year agreements.
- Drug discovery revenue for Q4 2024 increased 58% to $8.7 million, driven by the recognition of milestones.
- Net loss for Q4 2024 was $40.2 million, compared to a net loss of $30.7 million in Q4 2023.
Headline financials
Revenue & EPS history
Schrodinger · Revenue · Quarterly
$88.3M
Revenue by segment
Schrodinger · $13.7M total across 1 segment · Q3 2023
- Drug Discovery$13.7M+11.3%100.0%
Forward guidance
Schrödinger expects continued growth in software revenue and drug discovery revenue for fiscal year 2025, with a focus on managing operating expenses and improving cash flow from operations.
Tailwinds
- Software revenue growth is expected to range from 10% to 15% in 2025.
- Drug discovery revenue is expected to range from $45 million to $50 million in 2025.
- Operating expense growth in 2025 is expected to be less than 5%.
- Cash used for operating activities in 2025 is expected to be significantly lower than cash used in 2024.
- Software revenue for Q1 2025 is expected to range from $44 million to $48 million.
Headwinds
- Software gross margin is expected to range from 74% to 75% in 2025, which is lower than the 80% reported for FY 2024.
- The company did not provide specific net income or EPS guidance for 2025.
- No specific guidance on capital expenditures or other non-operating expenses was provided.
- The forward guidance is subject to various assumptions, uncertainties, and risks.
- The company did not provide specific targets for customer retention or ACV growth for 2025.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
-2.2%
Avg return
Earnings day
-1.6%
Avg return
5 days after
+1.8%
Avg return
30 days after
42%
11 / 26 earnings
Positive
+31.4%
Q4 2021
Best reaction
-29.9%
Q4 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.2% | +1.9% | +23.0% | |
| Q4 2025 | +8.3% | +5.9% | -6.1% | |
| Q3 2025 | -5.8% | -7.4% | -10.8% | |
| Q1 2025 | +0.6% | +0.2% | +3.8% | |
| Q4 2024 | +2.5% | -2.9% | -8.0% | |
| Q3 2024 | +13.1% | -5.1% | +7.8% | |
| Q2 2024 | +0.1% | -15.7% | -6.8% | |
| Q1 2024 | -4.9% | -1.4% | -11.7% | |
| Q4 2023 | -23.1% | -23.7% | -18.4% | |
| Q3 2023 | +15.3% | +27.5% | +49.7% | |
| Q2 2023 | -26.9% | -27.3% | -29.8% | |
| Q1 2023 | -5.1% | -6.4% | +22.3% | |
| Q4 2022 | +14.5% | +21.7% | +16.8% | |
| Q3 2022 | -14.6% | -15.6% | -29.2% | |
| Q2 2022 | +1.5% | -4.9% | -19.1% | |
| Q1 2022 | -5.5% | -10.5% | +1.5% | |
| Q4 2021 | +31.4% | +45.4% | +36.4% | |
| Q3 2021 | -16.1% | -15.6% | -31.6% | |
| Q2 2021 | -5.1% | -12.1% | -0.1% | |
| Q1 2021 | -6.8% | -4.3% | +19.4% | |
| Q4 2020 | -29.9% | -29.7% | -20.8% | |
| Q3 2020 | +12.4% | +15.8% | +39.6% | |
| Q3 2019 | +12.4% | +15.8% | +39.6% | |
| Q2 2020 | -2.5% | -2.4% | -24.2% | |
| Q1 2020 | -8.1% | +0.5% | +3.0% | |
| Q4 2019 | -14.6% | +8.3% | +1.5% | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro